Compositions and methods for enhancing brain function
View Patent ↗Compositions and methods are provided that enhance cognition in a human to which the composition is orally administered. Remarkably, clinical studies have proven that contemplated compositions achieved the desired effects using a minimal number of active ingredients at or near threshold active dosages, wherein such compositions almost exclusively comprise huperzine A, vinpocetine or rhodiola , and acetyl-L-carnitine, and optionally further include alpha lipoic acid, rhodiola , and biotin.
1. A method for enhancing cognitive function in a person comprising:
administering a nutritional supplement composition that includes huperzine A, vinpocetine, and acetyl-L-carnitine in a ratio of x:y:z, wherein x is between 0.8 and 1.2, y is between 80 and 120, and z is between 8,000 and 12,000; and
formulating the nutritional supplement composition for oral administration such that huperzine A, vinpocetine, and acetyl-L-carnitine, together account for at least 80 wt % of a dosage unit of the nutritional supplement composition.
2. The method according to claim 1 , and further comprising rhodiola, wherein x is between about 0.9 and about 1.1, y is between about 90 and about 110, and between about 1,800 and about 2,200 for rhodiola, and z is between about 9,000 and about 11,000.
3. The method according to claim 1 , wherein acetyl-L-carnitine is present in an amount from about 1250 mg to about 2000 mg.
4. The method according to claim 1 , wherein vinpocetine is present in an amount from about 10 mg to about 30 mg.
5. The method according to claim 1 , wherein rhodiola is present in an amount from about 250 mg to about 350 mg.
6. The method according to claim 1 , wherein huperzine A is present in an amount from about 50 mcg to about 200 mcg.
7. The method according to claim 1 , wherein the alpha lipoic acid is present in an amount from about 300 mg to about 500 mg.
8. The method according to claim 1 , further comprising biotin in an amount of about 400 mcg to about 600 mcg.
9. The method according to claim 1 , wherein the composition is formulated with an enteric coating.
10. The method according to claim 1 , further comprising an inactive ingredient selected from the group consisting of a carrier, a binder, an excipient, a dye, and combinations thereof.
11. The method according to claim 1 , wherein huperzine A, vinpocetine, and acetyl-L-carnitine together account for at least 90 wt % of a dosage unit of the composition.
12. The method according to claim 1 , wherein huperzine A, vinpocetine, and acetyl-L-carnitine together account for at least 95 wt % of the dosage unit of the composition.
13. The method according to claim 1 , wherein the dosage unit of the composition is equal or less than 1,200 mg.